Independent Directors
Dr. Thomas Insel
Director
- Psychiatrist
- Neuroscientist
- National Leader in Mental Health
- Director of the National Institute of Mental Health (NIMH), the component of the National Institutes of Health (NIH) committed to research on mental disorders, from 2002–2015
- Co-Director of President Obama’s BRAIN Initiative
- Led the Mental Health Team at Verily (formerly Google Life Sciences) in South San Francisco, CA. In 2017, co-founded Mindstrong Health, offering virtual care and psychiatric telehealth services for people with serious mental illness.
- In 2020, co-founded Humanestcare, a global therapeutic online community for recovery.
Dr. Peter Kash
Director
- 30 Year Wall Street Veteran
- Co-Founded More Than a Dozen Biotech Firms
- Six FDA-Approved Drugs Developed by Companies He Co-Founded
- Significant Experience Raising Private Equity Capital
- Co-founder and Vice-Chairman of TargImmune Therapeutics
- Co-founder and former partner of Two River Group
- Co-founder of PolaRx Biopharmaceuticals; developing the first cancer drug from China, Trienox approved by FDA.
- Co-founder and former Vice Chairman of Keryx Biopharmaceuticals
Bruce E. Roberts
Director
- 25+ years of International Banking Experience
- Expert in Strategic Investment in the Life Sciences, including:
- Biopharma
- Consumer-Digital Health
- Medical Technology
- Drug-Device Combination Devices
- Chairman of Nectero Medical
- Managing Director at RM Global Partners LLC
- General Partner of the RMGP Bio-Pharma Investment funds: deploying funds into innovative biopharma start-ups in Israel in collaboration with JNJ, Takeda, Bayer and Orbimed
- Managing Partner of Health Family Capital, LLC
- National Board of Directors of AdvaMed Accel
Advisors
Ambassador Ido Aharoni
- 25-year Veteran of Israel’s Foreign Service
- Public Diplomat Specialist
- Distinguished Professor at New York University’s Program of International Relations
- Member of the International Advisory Council (IAC) of global strategic communications firm DC-based APCO Worldwide
- Co-Founder and Principal at Israel based consultancy Emerson Rigby Ltd
- Advisor to Value Base™
- Chairman of the Charney Forum for New Diplomacy
Dr. Jacob Dagan
- 35-years of Healthcare Management
- Deep Experience in Corporate and Product Development, Operations, Marketing and Sales, Hospital Management, Biomedical Development
- CEO of DaganMD
- CEO and Founder of Medical Service Options, Inc.
- Director of Allium Medical, Ltd.
- Director IBI, Ltd
- Previously co-founded ProMed Capital LLC
Yair Ephrati
- 20 Years of Investment Banking and Corporate Finance experience, including M&A Transactions, Divestitures, and Public Equity Transactions
- Head of Investment Banking of Value Base™
- CEO and a Director of Value Base™ Mergers & Acquisitions Ltd
- Founded Y. Ephrati Capital & Management Advisors Ltd., a mid-market investment bank that was later merged into DS Apex Capital
- Founded Seed2Net, an internet related incubator that focused on founding companies in the telecommunication and internet arenas
- Chairman and CEO of Eden Energy Discoveries Ltd
- Board member to multiple organizations: Dan Public Transportation Corporation & Group Companies (2018 – present), Quidie Limited (2017 – present), VBARE Iberian Properties SOCIMI SA (2015 – present), and The Israeli Litigation Funding Fund (2018 – present).
Dr. Jacob Frenkel
- Chairman, Board of Trustees Group of Thirty, a Private, Nonprofit, Consultative Group on International Economic and Monetary Affairs
- Former Governor, Bank of Israel
- Former Chairman, JP Morgan Chase Int’l
- Former Professor, University of Chicago
- Chairman, Board of Governors, Tel Aviv University
- Fellow of the Econometric Society
- A Foreign Honorary Member of the American Academy of Arts and Sciences
- A member of the Board of Directors of the National Bureau of Economic Research of the Japan Society and of the Peterson Institute for International Economics.
- A member of Temasek International Panel (TIP)
- A member of the International Advisory Council of China Development Bank.
- A member of the Board of Directors of Boston Properties, Inc.
- A member of the Board of Directors of the Loews Corporation.
Dr. David Levy
- Chief Executive Officer at EHE Health
- An accomplished physician executive with a record of achievement in founding, leading, and/or turning around a variety of health care services companies
- Serves on the boards of leading: Medical device, Technology, and Services companies in the US, Israel, and Brazil
- Founded Franklin Health Inc., (now owned by Optum)
- Previously a Partner at PwC leading Global Healthcare business
Dr. Steven Miller
- Executive Vice President & Chief Clinical Officer Cigna Corporation
- A nationally recognized advocate for greater access, affordability and excellence in healthcare, leads all the Cigna’s clinical policy, quality and performance efforts
- Chief Medical Officer and Senior Vice President Express Scripts
- Improved health outcomes and value through e-prescribing, specialty solutions and overall product development.
- Chief Medical officer and Vice President at Barnes-Jewish Hospital, Washington University.
Edward Neugeboren
- 27 years experience in pharmaceutical operations, investment banking, business development, portfolio management, corporate management and institutional equity research
- Chief Strategy Officer of a pharmaceutical group comprised of Rising Pharma Holdings, Inc., a top US generic pharmaceutical company, Cronus Pharma, LLC, a leading animal health pharmaceutical company, Casper Pharma, LLC, a specialty pharmaceutical company and Grace Therapeutics, Inc., a rare and orphan central nervous pharmaceutical company.
- Founder and Managing Partner of QuadView Healthcare Advisors, previously named ArcLight Advisors, LLC, a healthcare investment banking and business development firm.
- Managing Director of Ledgemont Capital Group, LLC, an investment banking firm providing strategic and financial advisory services to growth companies with a specialty in Healthcare
- Managing Partner of Third Ridge Capital Management, LLC, a long/short U.S. equity hedge fund.
- Chief Administrative Officer and Director of Equity Research Operations at Lehman Brothers
- Managed the equity research business of Lehman’s strategic alliance with Fidelity Investments.
- Deputy Director of Equity Research at UBS, formerly Warburg Dillon Read
- Equity research analyst covering the Specialty Pharmaceuticals industry, including Generic Drugs and Drug Delivery at Dillon, Read & Co., Kidder, Peabody & Co., and Furman, Selz, Inc